| SPATA19 |
Q7Z5L4
|
spermatogenesis associated 19
|
|
3.5E-08 |
0.839 |
0.077 |
| ANP32C |
O43423
|
acidic nuclear phosphoprotein 32 family member C
|
Enzyme modulator
|
|
0.931 |
0.077 |
| RASAL3 |
Q86YV0
|
RAS protein activator like 3
|
Enzyme modulator
|
1.1E-10 |
0.839 |
0.077 |
| LOC110351180 |
|
IBSP 5' regulatory region
|
|
|
0.821 |
0.077 |
| RN7SK |
|
RNA component of 7SK nuclear ribonucleoprotein
|
|
|
0.931 |
0.077 |
| YIPF6 |
Q96EC8
|
Yip1 domain family member 6
|
|
0.90 |
0.890 |
0.077 |
| NAP1L6P |
A6NFF2
|
nucleosome assembly protein 1 like 6, pseudogene
|
|
|
0.890 |
0.077 |
| UBTD1 |
Q9HAC8
|
ubiquitin domain containing 1
|
Enzyme
|
0.75 |
0.931 |
0.077 |
| IDH1-AS1 |
|
IDH1 antisense RNA 1
|
|
|
0.931 |
0.077 |
| MIR4496 |
|
microRNA 4496
|
|
|
0.890 |
0.077 |
| TENT5B |
Q96A09
|
terminal nucleotidyltransferase 5B
|
|
0.18 |
0.931 |
0.077 |
| CDY2B |
Q9Y6F7
|
chromodomain Y-linked 2B
|
|
|
0.839 |
0.077 |
| FAM13C |
Q8NE31
|
family with sequence similarity 13 member C
|
|
5.8E-05 |
0.890 |
0.077 |
| MIR135A1 |
|
microRNA 135a-1
|
|
|
0.861 |
0.077 |
| LOC440040 |
|
glutamate metabotropic receptor 5 pseudogene
|
|
|
0.890 |
0.077 |
| ERVH-4 |
|
endogenous retrovirus group H member 4
|
|
|
0.861 |
0.077 |
| NIPSNAP1 |
Q9BPW8
|
nipsnap homolog 1
|
|
0.10 |
0.931 |
0.077 |
| RNASEK-C17orf49 |
|
RNASEK-C17orf49 readthrough
|
|
0.19 |
0.890 |
0.077 |
| MIR4534 |
|
microRNA 4534
|
|
|
0.890 |
0.077 |
| ARLNC1 |
|
androgen receptor regulated long noncoding RNA 1
|
|
|
0.890 |
0.077 |
| TBC1D3G |
Q6DHY5 Q6IPX1 Q8IZP1
|
TBC1 domain family member 3G
|
|
|
0.931 |
0.077 |
| PCSEAT |
|
prostate cancer expressed EZH2 associated transcript
|
|
|
0.890 |
0.077 |
| C17orf49 |
Q8IXM2
|
chromosome 17 open reading frame 49
|
|
6.9E-02 |
0.890 |
0.077 |
| PATE1 |
Q8WXA2
|
prostate and testis expressed 1
|
|
7.4E-09 |
0.890 |
0.077 |
| HMGN2P46 |
Q86SG4
|
high mobility group nucleosomal binding domain 2 pseudogene 46
|
Nucleic acid binding
|
|
0.890 |
0.077 |